A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.

Microarray analyses were performed on livers from adrenalectomized male Wistar rats chronically infused with methylprednisolone (MPL) (0.3 mg/kg.h) using Alzet mini-osmotic pumps for periods ranging from 6 h to 7 d. Four control and 40 drug-treated animals were killed at 10 different times during drug infusion. Total RNA preparations from the livers of these animals were hybridized to 44 individual Affymetrix REA230A gene chips, generating data for 15,967 different probe sets for each chip. A series of three filters were applied sequentially. These filters were designed to eliminate probe sets that were not expressed in the tissue, were not regulated by the drug, or did not meet defined quality control standards. These filters eliminated 13,978 probe sets (87.5%) leaving a remainder of 1989 probe sets for further consideration. We previously described a similar dataset obtained from animals after administration of a single dose of MPL (50 mg/kg given iv). That study involved 16 time points over a 72-h period. A similar filtering schema applied to the single-bolus-dose dataset identified 1519 probe sets as being regulated by MPL. A comparison of datasets from the two different dosing regimens identified 358 genes that were regulated by MPL in response to both dosing regimens. Regulated genes were grouped into 13 categories, mainly on gene product function. The temporal profiles of these common genes were subjected to detailed scrutiny. Examination of temporal profiles demonstrates that current perspectives on the mechanism of glucocorticoid action cannot entirely explain the temporal profiles of these regulated genes.

[1]  Bialas Mc,et al.  Adverse effects of corticosteroids. , 1998 .

[2]  Frauman Ag,et al.  An overview of the adverse reactions to adrenal corticosteroids. , 1996 .

[3]  C. Allis,et al.  Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.

[4]  Richard R. Almon,et al.  Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  J. Papamatheakis,et al.  Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Hamman,et al.  DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile. , 2000, Atherosclerosis.

[7]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[8]  Eric P. Hoffman,et al.  The PEPR GeneChip data warehouse, and implementation of a dynamic time series query tool (SGQT) with graphical interface , 2004, Nucleic Acids Res..

[9]  Jin Y. Jin,et al.  Receptor/Gene-Mediated Pharmacodynamic Effects of Methylprednisolone on Phosphoenolpyruvate Carboxykinase Regulation in Rat Liver , 2004, Journal of Pharmacology and Experimental Therapeutics.

[10]  Debra C DuBois,et al.  The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series. , 2004, Pharmacogenomics.

[11]  John A Cidlowski,et al.  Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. , 2005, Molecular cell.

[12]  N. Kaminski Microarray analysis of idiopathic pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.

[13]  D. DuBois,et al.  Corticosteroid effects in skeletal muscle: Gene induction/receptor autoregulation , 1997, Muscle & nerve.

[14]  Jin Y. Jin,et al.  Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series , 2005, The AAPS Journal.

[15]  R. Hanson,et al.  Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. , 1997, Annual review of biochemistry.

[16]  B. Walker,et al.  Human insulin resistance: the role of glucocorticoids , 2003, Diabetes, obesity & metabolism.

[17]  S. Matsufuji,et al.  Cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme inhibitor. , 1997, Biochimica et biophysica acta.

[18]  T. Jatkoe,et al.  The G0/G1 switch gene 2 is a novel PPAR target gene. , 2005, The Biochemical journal.

[19]  M. Takiguchi,et al.  Human liver-type arginase gene: structure of the gene and analysis of the promoter region. , 1988, Nucleic acids research.

[20]  J. Enghild,et al.  Idiopathic Pulmonary Fibrosis , 2003 .

[21]  G. Crabtree,et al.  Potential basis for regulation of the coordinately expressed fibrinogen genes: homology in the 5' flanking regions. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Ramakrishnan,et al.  Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[23]  Y. Murakami,et al.  Involvement of antizyme-like regulatory protein in polyamine-caused repression of ornithine decarboxylase in insect-derived Trichoplusia ni 5 cells. , 1997, Biochimica et biophysica acta.

[24]  S. Broitman,et al.  A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat. , 1982, The Biochemical journal.

[25]  Richard R. Almon,et al.  Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[26]  R. Farr,et al.  Abnormal liver-function tests associated with long-term systemic corticosteroid use in subjects with asthma. , 1991, Journal of Allergy and Clinical Immunology.

[27]  G. Mize,et al.  Transcription Factor ZBP-89 Regulates the Activity of the Ornithine Decarboxylase Promoter* , 1998, The Journal of Biological Chemistry.

[28]  D. Moore,et al.  An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.

[29]  D. DuBois,et al.  Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. , 1999, The Journal of pharmacology and experimental therapeutics.

[30]  Y. Kanai,et al.  Identification of multispecific organic anion transporter 2 expressed predominantly in the liver , 1998, FEBS letters.

[31]  Debra C DuBois,et al.  Corticosteroid-regulated genes in rat kidney: mining time series array data. , 2005, American journal of physiology. Endocrinology and metabolism.

[32]  L. Lőcsey,et al.  Dyslipidaemia and hyperlipidaemia following renal transplantation , 2006, International Urology and Nephrology.

[33]  N. Friedman,et al.  Statistical methods for analyzing gene expression data for cancer research. , 2002, Ernst Schering Research Foundation workshop.

[34]  Sugden Mc,et al.  Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia. , 2002 .

[35]  Debra C DuBois,et al.  Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[36]  A. Willis,et al.  Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q , 1994, The Journal of experimental medicine.

[37]  D. Granner,et al.  The genes of hepatic glucose metabolism. , 1990, The Journal of biological chemistry.

[38]  K. Reid,et al.  Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1–1p36.3 , 2004, Immunogenetics.

[39]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[40]  D. Comings,et al.  Sequence of human tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. , 1995, Genomics.